Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
Authors:
Open Access
- 14 July 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Liver Disease
- Vol. 41 (04) , 495-506
Abstract
The human gut harbors a dense and highly diverse microbiota of approximately 1,000 bacterial species. The interaction between the host and gut bacteria strongly influences human health. Numerous evidence suggest that intestinal flora imbalance is closely associated with the development and treatment of liver diseases, including acute liver injury and chronic liver diseases (cirrhosis, autoimmune liver disease, and fatty liver). Therefore, regulating the gut microbiota is expected to be a new method for the adjuvant treatment of liver diseases. Fecal microbiota transplantation (FMT) is defined as the transplantation of gut microbiota from healthy donors to sick patients via the upper or lower gastrointestinal route to restore the normal intestinal balance. In this study, we briefly review the current research on the gut microbiota and its link to liver diseases and then summarize the evidence to elucidate the clinical application and development of FMT in liver disease treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81904129)
- College Student Innovation Funds Project for the Hebei University of Chinese Medicine (31800952)
- College Student Innovation Funds Project for the Hebei University of Chinese Medicine (202014432203)
- Fundamental Research Funds for the Southeast University (3218006405)
- Fundamental Research Funds for the Southeast University (2242019s10024)
This publication has 96 references indexed in Scilit:
- Intestinal microbiota determines development of non-alcoholic fatty liver disease in miceGut, 2012
- The Impact of the Gut Microbiota on Human Health: An Integrative ViewCell, 2012
- Linkage of gut microbiome with cognition in hepatic encephalopathyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Treating Clostridium difficile Infection With Fecal Microbiota TransplantationClinical Gastroenterology and Hepatology, 2011
- Investigating the biological and clinical significance of human dysbiosesTrends in Microbiology, 2011
- Gut microbiota and probiotics in chronic liver diseasesDigestive and Liver Disease, 2011
- Microbiology in the post-genomic eraNature Reviews Microbiology, 2008
- The Effect of Faecal Enema on Five Microflora-Associated Characteristics in Patients with Antibiotic-Associated DiarrhoeaScandinavian Journal of Gastroenterology, 1999
- Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation.Journal of Hepatology, 1995
- RELAPSING CLOSTRIDIUM DIFFICILE ENTEROCOLITIS CURED BY RECTAL INFUSION OF HOMOLOGOUS FAECESThe Lancet, 1983